Short Report
TLR9-adjuvanted pneumococcal conjugate vaccine induces antibody-independent memory responses in HIV-infected adults
Downloads and Tools
Volume 8, Issue 8 August 2012
Pages 1042 - 1047
http://dx.doi.org/10.4161/hv.20707
Keywords: CpG-ODN, HIV, TLR9, adjuvants, cellular memory, pneumococcal vaccine
Authors: Rasmus Offersen, Jesper Melchjorsen, Søren R. Paludan, Lars Østergaard, Martin Tolstrup and Ole S. Søgaard
View affiliations Hide affiliations
- Rasmus Offersen
-
Corresponding author: rasmus.offersen@gmail.com
Department of Infectious Diseases; Aarhus University Hospital; Aarhus, Denmark
- Jesper Melchjorsen
-
Department of Infectious Diseases; Aarhus University Hospital; Aarhus, Denmark
- Søren R. Paludan
-
Department of Biomedicine; Aarhus University; Aarhus, Denmark
- Lars Østergaard
-
Department of Infectious Diseases; Aarhus University Hospital; Aarhus, Denmark
- Martin Tolstrup
-
Department of Infectious Diseases; Aarhus University Hospital; Aarhus, Denmark
- Ole S. Søgaard
-
Corresponding author: olesoega@rm.dk
Department of Infectious Diseases; Aarhus University Hospital; Aarhus, Denmark
Abstract:
HIV-patients have excess of pneumococcal infection. We immunized 40 HIV-patients twice with pneumococcal conjugate vaccine (Prevnar, Pfizer) +/− a TLR9 agonist (CPG 7909). Peripheral blood mononuclear cells were stimulated with pneumococcal polysaccharides and cytokine concentrations measured. The CPG 7909 adjuvant group had significantly higher relative cytokine responses than the placebo group for IL-1β, IL-2R, IL-6, IFN-γ and MIP-β, which, did not correlate with IgG antibody responses. These findings suggests that CPG 7909 as adjuvant to pneumococcal conjugate vaccine induces cellular memory to pneumococcal polysaccharides in HIV-patients, independently of the humoral response.
Received: February 26, 2012; Accepted: May 10, 2012; Published Online: August 1, 2012
Preview: